George PrayGod

Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania

Zacchaeus Anywaine, Hilary Whitworth, Pontiano Kaleebu et al. · The Journal of Infectious Diseases · 2019 · 153 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Diabetes Is a Risk Factor for Pulmonary Tuberculosis: A Case-Control Study from Mwanza, Tanzania

Daniel Faurholt‐Jepsen, Nyagosya Range, George PrayGod et al. · PLoS ONE · 2011 · 147 citations · Full text

Public Health, Health Sciences, Infectious Diseases +12

Microbiota at Multiple Body Sites during Pregnancy in a Rural Tanzanian Population and Effects of Moringa-Supplemented Probiotic Yogurt

Jordan E. Bisanz, Megan K. Enos, George PrayGod et al. · Applied and Environmental Microbiology · 2015 · 115 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from <scp>M</scp> wanza, <scp>T</scp> anzania

Daniel Faurholt‐Jepsen, Nyagosya Range, George PrayGod et al. · Tropical Medicine & International Health · 2013 · 113 citations

Medicine, Infectious Diseases, Internal Medicine +15

The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis

Martine G. Aabye, Pernille Ravn, George PrayGod et al. · PLoS ONE · 2009 · 110 citations · Full text

Public Health, Clinical Sciences, Infectious Diseases +17